Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-57.27	25.11	58.77
Graham Fair Price	43.06	67.07	46.88
PEG	-99.27	< 0.005	-0.10
Price/Book	5.70	0.75	0.71
Price/Cash Flow	-37.81	37.79	60.76
Prices/Earnings	-45.25	5.44	9.93
Price/Sales	10.07	1.12	1.01
Price/FCF	-37.81	37.79	60.76
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	472.91	0.04	< 0.005
Operating Margin	79.94	0.07	0.04
ROA	95.24	0.01	< 0.005
ROE	0.02	0.03	93.06
ROIC	0.01	0.02	71.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.04	-25.69
Dividends QOQ	-1.00	-1.00	< 0.005
EBIT QOQ	-0.68	0.78	15.59
EPS QOQ	-0.99	74.50	7404.12
FCF QOQ	-0.48	0.75	56.24
Revenue QOQ	-0.04	< 0.005	73.64
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	40.81	42.62	4.43
Days Sales Outstanding (DSO)	27.64	27.74	0.35
Inventory Turnover	2.21	2.11	-4.24
Debt/Capitalization	0.53	0.53	0.08
Quick Ratio	0.95	1.11	17.16
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	74.12	76.31	2.96
Cash	15.39	16.30	5.91
Capex	-2.77	-1.92	30.56
Free Cash Flow	0.86	1.51	75.01
Revenue	51.63	51.05	-1.13
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.71	1.96	14.79
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	33.56	13.85	-58.73
Naive Interpretation	Member

06 - Financial Health · Weak

Rating